| abstract |
The present invention relates to a pharmaceutical composition containing cefuroxine axetil wherein the active ingredient is not gelled by moisture absorption and is thus stable during storage period. More specifically, the present invention relates to a pharmaceutical composition which comprises amorphous cefuroxime axetil as an active ingredient and silicon dioxide or its hydrate as a micro-environmental pH adjustor and an anti-gelling agent for cefuroxime axetil. The composition according to the present invention can be provided in the oral formulation such as tablets, capsules, granules, powders and dry syrups. |